Corrigendum to “Development and validation of a sensitive LC–MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients” [J. Pharmaceut. Biomed. Anal. 237 (2024) 115758]

Journal of Pharmaceutical and Biomedical Analysis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles